A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)
Clinical trial NCT03859869 · TERMINATED
Trial details
- NCT number
- NCT03859869
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-25
- Primary completion
- 2022-03-23
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.